Recent News

• 06.12.2025 - Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
• 06.12.2025 - Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
• 06.04.2025 - Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream
• 06.04.2025 - Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream
• 05.13.2025 - Daré Bioscience, Inc. Q1 2025 Conference Call
• 05.13.2025 - Daré Bioscience, Inc. Q1 2025 Conference Call
• 05.13.2025 - Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
• 05.13.2025 - Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
• 05.06.2025 - Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025
• 05.06.2025 - Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025

Recent Filings

• 06.09.2025 - 8-K Current report
• 06.09.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 8-K Current report
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.24.2025 - DEF 14A Other definitive proxy statements
• 04.24.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2025 - ARS Annual Report to Security Holders